F-Prime Capital

  • People
  • Portfolio
  • Impact
  • Home
  • People
  • Portfolio
    • Life Sciences
    • Technology
    • Healthtech + Services
    • Crypto
  • Impact
  • About
  • Jobs
  • Fintech Index
hero

Join the teams building tomorrow.

Search 
jobs
Explore 
companies
Join talent network
Talent
My job alerts

On-site & Remote

Seniority
Salary
Company
Powered by Getro
Showing 4 jobs
Paradigm

Data Scientist, Commercial Analytics

Paradigm
Remote
24 days
Health
Hospital & Health Care
51 - 200 employees
Series A
Mid-Senior Level
Read more
about Data Scientist, Commercial Analytics at Paradigm
Orchard Therapeutics

Principal Scientist, Global Technical Development

Orchard Therapeutics
London, UK
21 days
Biotechnology
201 - 1000 employees
IPO
Senior
Read more
about Principal Scientist, Global Technical Development at Orchard Therapeutics
Orchard Therapeutics

Principal Scientist, Viral Vector Development

Orchard Therapeutics
London, UK
21 days
Biotechnology
201 - 1000 employees
IPO
Senior
Read more
about Principal Scientist, Viral Vector Development at Orchard Therapeutics
Orchard Therapeutics

Data Scientist, MSAT

Orchard Therapeutics
London, UK
2 months
Biotechnology
201 - 1000 employees
IPO
Mid-Senior Level
Read more
about Data Scientist, MSAT at Orchard Therapeutics
Privacy policyCookie policy

Life Sciences
Technology
Healthtech + Services
Crypto

About
Jobs
Fintech Index

LinkedIn
X

Cambridge
1 Main St. 13th Floor
Cambridge, MA 02142
London
33 Foley Street
London, W1W 7TL
San Francisco
140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105

The information on these pages is intended solely for the benefit of entrepreneurs seeking venture capital investments. F-Prime is not offering investment advisory services nor is it offering to sell securities. F‑Prime provides advisory services as Impresa Management LLC. The list of portfolio companies includes investments made by Fidelity Ventures and Eight Roads. FBRI is an affiliate of F‑Prime and a subsidiary of FMR LLC. As of July 1, 2024, F-Prime advises Fine Structure Ventures (finestructure.vc).

©2025 F-Prime    Terms of Use    Privacy Policy